Form D · Other Health Care
Affect Therapeutics, Inc.
Mc Lean, VA · CIK 0001883067
Offering snapshot reported Jul 12, 2023 · SEC filing
- Reported sold
- $18.1M Offering amount: $18.1M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 16, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 12, 2023 | Initial | $18,073,362 | No comparison | 9 | SEC filing |
| Sep 23, 2021 | Initial | $6,504,278 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-486606
The total amount sold includes convertible notes and the securities issuable hereto.
Source: Form D, filed Jul 12, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeff De Flavio | Director |
| Kristin Muhlner | Director, Executive |
| Stuart Peterson | Director |
| Jeff Rinehart | Director |
| Kevin Ryan | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1640 Boro Place 4th Floor
Mc Lean, VA, 22102
Mc Lean, VA, 22102